These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20439437)

  • 21. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
    Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L
    Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of S100B confers resistance to experimental diabetes in mice.
    Mohammadzadeh F; Tsoporis JN; Izhar S; Desjardins JF; Parker TG
    Exp Cell Res; 2018 Apr; 365(1):129-137. PubMed ID: 29499206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel culture technique involving an histone deacetylase inhibitor reduces the marginal islet mass to correct streptozotocin-induced diabetes.
    Shin JS; Min BH; Lim JY; Kim BK; Han HJ; Yoon KH; Kim SJ; Park CG
    Cell Transplant; 2011; 20(9):1321-32. PubMed ID: 21294957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
    Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
    Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
    Shen L; Peng H; Zhao S; Xu D
    Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
    Wagner K; Yang J; Inceoglu B; Hammock BD
    J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia.
    Chang TJ; Weaver JR; Bowman A; Leone K; Raab R; Vinik AI; Pittenger GL; Taylor-Fishwick DA
    Mol Cell Endocrinol; 2011 Mar; 335(2):104-9. PubMed ID: 21187123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats.
    Iyer A; Kauter K; Alam MA; Hwang SH; Morisseau C; Hammock BD; Brown L
    Exp Diabetes Res; 2012; 2012():758614. PubMed ID: 22007192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion.
    Hasegawa G; Yamasaki M; Kadono M; Tanaka M; Asano M; Senmaru T; Kondo Y; Fukui M; Obayashi H; Maruyama N; Nakamura N; Ishigami A
    Endocrinology; 2010 Feb; 151(2):529-36. PubMed ID: 19934374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction.
    Savina Y; Duflot T; Bounoure F; Kotzki S; Thiebaut PA; Serreau PA; Skiba M; Picquenot JM; Cornic M; Morisseau C; Hammock B; Imbert L; Cracowski JL; Richard V; Roustit M; Bellien J
    Diab Vasc Dis Res; 2019 Nov; 16(6):523-529. PubMed ID: 31267765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
    Sako Y; Grill VE
    Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic deficiency or pharmacological inhibition of soluble epoxide hydrolase ameliorates high fat diet-induced pancreatic β-cell dysfunction and loss.
    Koike S; Hsu MF; Bettaieb A; Chu B; Matsumoto N; Morisseau C; Havel PJ; Huising MO; Hammock BD; Haj FG
    Free Radic Biol Med; 2021 Aug; 172():48-57. PubMed ID: 34038767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.
    Guglielmino K; Jackson K; Harris TR; Vu V; Dong H; Dutrow G; Evans JE; Graham J; Cummings BP; Havel PJ; Chiamvimonvat N; Despa S; Hammock BD; Despa F
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H853-62. PubMed ID: 22865388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
    Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
    Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of soluble epoxide hydrolase (sEH) protects hippocampal neurons and reduces cognitive decline in type 2 diabetic mice.
    Wu J; Fan Z; Zhao Y; Chen Q; Xiao Q
    Eur J Neurosci; 2021 Apr; 53(8):2532-2540. PubMed ID: 33595911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble Epoxide Hydrolase Blockade after Stroke Onset Protects Normal but Not Diabetic Mice.
    Davis CM; Zhang WH; Allen EM; Bah TM; Shangraw RE; Alkayed NJ
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase: gene structure, expression and deletion.
    Harris TR; Hammock BD
    Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.
    Minaz N; Razdan R; Hammock BD; Mujwar S; Goswami SK
    Biomed Pharmacother; 2019 Jul; 115():108897. PubMed ID: 31102913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of preproglucagon peptides in regulating β-cell morphology and responses to streptozotocin-induced diabetes.
    Arble DM; Hutch CR; Hafner H; Stelmak D; Leix K; Sorrell J; Pressler JW; Gregg B; Sandoval DA
    Am J Physiol Endocrinol Metab; 2023 Mar; 324(3):E217-E225. PubMed ID: 36652401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.